These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8466723)
21. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II). Crouse JR; Byington RP; Bond MG; Espeland MA; Craven TE; Sprinkle JW; McGovern ME; Furberg CD Am J Cardiol; 1995 Mar; 75(7):455-9. PubMed ID: 7863988 [TBL] [Abstract][Full Text] [Related]
22. Interventional clinical trials using noninvasive ultrasound end points: the Multicenter Isradipine/Diuretic Atherosclerosis Study. The MIDAS Research Group. Bond MG; Strickland HL; Wilmoth SK; Safrit A; Phillips R; Szostak L J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S30-3. PubMed ID: 1695299 [TBL] [Abstract][Full Text] [Related]
23. Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens. Sihm I; Schroeder AP; Aalkjaer C; Mulvany MJ; Thygesen K; Lederballe O Am J Hypertens; 1998 Mar; 11(3 Pt 1):263-71. PubMed ID: 9544865 [TBL] [Abstract][Full Text] [Related]
24. [Ultrasonographic assessment of carotid atherosclerosis emphasizing the variety of intimal-medial thickness and the relationship with coronary risk factors]. Sugo A; Nakajima S; Kurata T; Mokuno H; Daida H; Yamaguchi H J Cardiol; 1997 Dec; 30(6):321-9. PubMed ID: 9436074 [TBL] [Abstract][Full Text] [Related]
25. Effects of isradipine, a new calcium antagonist, versus hydrochlorothiazide on serum lipids and apolipoproteins in patients with systemic hypertension. Samuel P; Kirkendall W; Schaefer EJ; Chin B; Schoenfeld BH; Gonasun LM; Lieberman S Am J Cardiol; 1988 Nov; 62(16):1068-71. PubMed ID: 2973219 [TBL] [Abstract][Full Text] [Related]
26. [High-resolution ultrasonographic study of atherosclerotic lesions of the carotid arteries in borderline essential arterial hypertension]. Pellegrino L; Prencipe G G Ital Cardiol; 1994 Oct; 24(10):1199-210. PubMed ID: 7835550 [TBL] [Abstract][Full Text] [Related]
27. Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension. Brogden RN; Sorkin EM Drugs; 1995 Apr; 49(4):618-49. PubMed ID: 7789292 [TBL] [Abstract][Full Text] [Related]
28. Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind trial. Zanchetti A; Crepaldi G; Bond MG; Gallus G; Veglia F; Mancia G; Ventura A; Baggio G; Sampieri L; Rubba P; Sperti G; Magni A; Stroke; 2004 Dec; 35(12):2807-12. PubMed ID: 15514192 [TBL] [Abstract][Full Text] [Related]
29. Effect of isradipine, a new calcium antagonist on the lipid profile in patients with hypertension. Samuel P Cor Vasa; 1990; 32(2 Suppl 1):35-41. PubMed ID: 2143459 [TBL] [Abstract][Full Text] [Related]
30. Association of common carotid intima-media thickness and lipoprotein(a) with coronary artery disease. Tewari S; Garg N; Kapoor A; Jain A; Singh U; Godbole MM; Sinha N Indian Heart J; 2004; 56(6):642-5. PubMed ID: 15751520 [TBL] [Abstract][Full Text] [Related]
31. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing. Pelttari LH; Hietanen EK; Salo TT; Kataja MJ; Kantola IM Am J Hypertens; 1998 Mar; 11(3 Pt 1):272-9. PubMed ID: 9544866 [TBL] [Abstract][Full Text] [Related]
32. Long-term lipid profiles with isradipine and hydrochlorothiazide treatment in elderly hypertensive patients. Stein GH; Matthews K; Bannatyne RE; Quay G; Lopez L; McCarley D J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S90-2. PubMed ID: 1695313 [TBL] [Abstract][Full Text] [Related]
33. Potential modification of plaque behavior through the European lacidipine study on atherosclerosis. Bond MG; Mercuri M J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S11-6. PubMed ID: 8852539 [TBL] [Abstract][Full Text] [Related]
34. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The Asymptomatic Carotid Artery Plaque Study. Riley WA; Barnes RW; Applegate WB; Dempsey R; Hartwell T; Davis VG; Bond MG; Furberg CD Stroke; 1992 Aug; 23(8):1062-8. PubMed ID: 1636178 [TBL] [Abstract][Full Text] [Related]
35. Atherosclerosis and calcium antagonists: the VHAS. The Verapamil-Hypertension Atherosclerosis Study (VHAS) Investigators. Zanchetti A; Magnani B; Dal Palù C J Hum Hypertens; 1992 Dec; 6 Suppl 2():S45-8. PubMed ID: 1289514 [TBL] [Abstract][Full Text] [Related]
36. Effect of isradipine on in-vivo platelet function. O'Grady J; Kritz H; Schmid P; Pirich C; Sinzinger H Thromb Res; 1997 Jun; 86(5):363-71. PubMed ID: 9211627 [TBL] [Abstract][Full Text] [Related]
37. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation. Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945 [TBL] [Abstract][Full Text] [Related]
38. Trials investigating the anti-atherosclerotic effects of antihypertensive drugs. Zanchetti A J Hypertens Suppl; 1996 Sep; 14(2):S77-80; discussion S80-1. PubMed ID: 8934382 [TBL] [Abstract][Full Text] [Related]
39. Modifying the natural history of atherosclerosis: the SECURE trial. Lonn E Int J Clin Pract Suppl; 2001 Jan; (117):13-8. PubMed ID: 11715353 [TBL] [Abstract][Full Text] [Related]